A human pituitary tumor-derived folliculostellate cell line

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 3, 2000, Pages 1180-1187

  Danila, Daniel C ^a   Zhang, Xun ^a   Zhou, Yunli ^a   Dickersin, G Richard ^a   Fletcher, Jonathan A ^b   Hedley Whyte, E Tessa ^a   Selig, Martin K ^a   Johnson, Stacey R ^a   Klibanski, Anne ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; PROTEIN S 100; TRANSFORMING GROWTH FACTOR BETA; VIMENTIN;

ARTICLE; CELL GROWTH; CELL JUNCTION; CELL LINE; CELL STRUCTURE; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DESMOSOME; ELECTRON MICROSCOPY; EXPERIMENTAL MODEL; HORMONAL REGULATION; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; HYPOPHYSIS ADENOMA; HYPOPHYSIS FUNCTION; HYPOPHYSIS TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STELLATE CELL;

ACTIVIN RECEPTORS; ACTIVINS; ADENOMA; AGED; BLOTTING, WESTERN; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOLLISTATIN; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBINS; LUCIFERASES; MALE; MICROSCOPY, ELECTRON; MUTATION; PITUITARY NEOPLASMS; RECEPTORS, GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034454009     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.3.1180     Document Type: Article

References (79)

1. The effects of activin on follicle-stimulating hormone secretion and biosynthesis in human glycoprotein hormone-producing pituitary adenomas
2. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids
3. Neuropeptide expression in human pituitary cell lines
4. Oestradiol, vasoactive intestinal peptide and fibroblast growth factor in the growth of human pituitary tumour cells in vitro
5. Lactotrophs and gonadotrophs
6. Stimulatory effect of thyroid hormone on growth hormone gene expression in a human pituitary cell line
7. Immortalized human pituitary cells express glycoprotein alpha-subunit and thyrotropin beta (TSH beta)
8. Evidence that stimulation of growth hormone release by epinephrine and vasoactive intestinal peptide is based on cell-to-cell communication in the pituitary
9. Folliculo-stellate cells and intercellular communication within the rat anterior pituitary, gland
10. Pituitary follicular cells secrete both vascular endothelial growth factor and follistatin
11. Follistatin gene expression in the pituitary: Localization in gonadotropes and folliculostellate cells in diestrous rats
12. A two-site chemilurrunescent assay for activin-free follistatin reveals that most follistatin circulating in men and normal cycling women is in an activin-bound state
13. Lipocortin-1 immunoreactivity in the human pituitary gland
14. Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis
15. Modulation of the hypothalamo-pituitary adrenocortical response to cytokines in the rat by lipocortin 1 and glucocorticoids: A role for lipocortin 1 in the feedback inhibition of CRF-41 release?
16. Differentiating neuroblas toma of pituitary gland: Neuroblastic transformation of epithelial adenoma cells. Case report
17. Regulation of prolactin gene ex pression in a DMBA-estrogen-induced transplantable rat pituitary tumor
18. Cellular distribution and gene regulation of estrogen receptors α and β in the rat pituitary gland
19. Ultrastructural morphology of folliculo-stellate cells in human pituitary adenomas
20. Tumor necrosis factor receptors in the pituitary cells
21. Regulation and role of intrapituitary IL-6 production by folliculostellate cells
22. Interleukin-6 is an autocrine growth factor for folliculostellate-like TtT/GF mouse pituitary tumor cells
23. Immtmocytochemical evidence that S-100-positive cells of the mouse anterior pituitary contain interleukin-6 immunoreactivity
24. Immunohistochemical study for basic fibroblast growth factor and fibroblast growth factor receptor I in pituitary adenomas
25. Folliculo-stellate cells in pituitary adenomas of patients with acromegaly
26. The presence of glial fibrillary acidic protein in the human pituitary gland
27. Panhypopituitarism due to Rathke's cleft cyst associated with pituitary oncocytoma
28. Ultrastructural morphology of folliculo-stellate cells in human pituitary adenomas
29. Differentiating neuroblas toma of pituitary gland: Neuroblastic transformation of epithelial adenoma cells. Case report
30. Folliculo-stellate cells of human pituitary adenomas: Immunohistochemical study of the monocyte/macro phage phenotype expression
31. Dopaminergic regulation of α-subunit secretion and messenger ribonucleic acid levels in alpha-secreting pituitary tumors
32. Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors
33. A tumor-specific truncated estrogen receptor splice variant enhances estrogen-stimulated gene expression
34. Activation of MAP kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 373 cells
35. Structure, expression, and function of human pituitary tumor-transforming gene (PTTG)
36. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
37. Tumor-specific expression and alternate splicing of messenger ribonucleic acid en coding activin/transforming growth factor-β receptors in human pituitary adenomas
38. Selective induction of apoptosis by the cytotoxic analog AN-207 in cells expressing recombinant receptor for luteinizing hormone-releasing hormone
39. Further characterization of retinoblastoma gene-mediated cell growth and tumor suppression in human cancer cells
40. Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression
41. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form
42. TGFβ signals through a heteromeric protein kinase receptor complex
43. In activation of activin-dependent transcription by kinase-deficient activin receptors
44. Expression of Ca(2+)-binding proteins of the S100 family in malignant human breast-cancer cell lines and biopsy samples
45. Mutations in the p53 gene occur in diverse human tumour types
46. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene
47. p53 functions as a cell cycle control protein in osteosarcomas
48. Cytokeratins in intracranial and intraspinal tissues
49. S-100 protein in folliculostel late cells of the rat pituitary anterior lobe
50. Novel clonal strains from adult rat anterior pituitary producing S-100 protein
51. Previously unreported "hemidesmosomal junctions" between folliculo-stellate cells and pituitary adenoma cells
52. Intercellular junctions in the rhesus monkey pars distalis
53. Ras induces anchorage-independent growth by subverting multiple adhesion-regulated cell cycle events
54. Genes involved in the control of cellular proliferative potential
55. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells
56. The molecular basis of oncogenes and tumor suppressor genes
57. Cancer cell cycles
58. p53: Puzzle and paradigm
59. The tumor suppressor protein p16INK4a
60. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
61. The cytogenesis and pathogenesis of pituitary adenomas
62. Mdm2 promotes the rapid deg radation of p53
63. Regulation of p53 stability by Mdm2
64. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: A comparison of the "hot spot" mutant phenotypes
65. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts
66. A case of pituitary adenoma with 58 chromosomes
67. Multiple genetic aberrations including evidence of chromosome 11q13 rearrangement detected in pituitary adenomas by comparative genomic hybridization
68. Activin receptors and cellular signaling by the receptor serine kinase family
69. Structural characterization of follistatin: A novel follicle-stimulating hormone release-inhibiting polypeptide from the gonad
70. Identification of naturally occurring follistatin complexes in human biological fluids
71. Follistatin gene expression in the ovary and extragonadal tissues
72. Inhibins, activins and follistatins
73. Rat follistatin: Gonadal and extragonadal expression and evidence for alternative splicing
74. Follistatin gene expression in the pituitary: Localization in gonadotropes and folliculostellate cells in diestrous rats
75. Inhibin, activin, and follistatin: Regulation of follicle-stimulating hormone messenger ribonucleic acid levels
76. Inhibition of somatotroph growth and growth hormone biosynthesis by activin in vitro
77. Transforming growth factor-beta and activin inhibit basal secretion of prolactin in a pituitary monolayer culture system
78. Decreased follistatin gene expression in gonadotroph adenomas